\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ is\\ currently\\ undergoing\\ workup\\ for\\ mass\\ and\\ pending\\ neurological\\ consultation\\.\ \(0\)\
\-\ a\\ bilobed\\ extraaxial\\ mass\\ with\\ a\\ broad\\ dural\\ base\\ and\\ dural\\ tail\\ surrounding\\ the\\ interclinoid\\ ligament\\ with\\ transosseous\\ extension\\ into\\ the\\ cavernous\\ sinus\\ with\\ a\\ tubular\\ component\\ extending\\ into\\ the\\ foramen\\ ovale\\ and\\ a\\ broad\\ component\\ extending\\ into\\ the\\ right\\ quadrigeminal\\ plate\\ cistern\\.\ \(0\)\
\-\ meningioma\ \(167\)\
\-\ solitary\\ meningioma\ \(0\)\
\-\ meningioma\\ and\\ trigeminal\\ schwannoma\\ \\(neurofibromatosis\\ 2\\)\ \(0\)\
\-\ 46\\ year\\ old\\ who\\ initially\\ had\\ right\\ perioral\\ paresthesias\\ and\\ subjective\\ hearing\\ loss\\ presented\\ with\\ worsening\\ paresthesias\\ and\\ pain\\ involving\\ the\\ mandibular\\ distribution\\ of\\ the\\ trigeminal\\ nerve\\.\ \(1\)\
\-\ in\\ unenhanced\\ exams\\ meningiomas\\ are\\ slightly\\ hyperdense\\ compared\\ to\\ schwannomas\\ which\\ are\\ isodense\\ or\\ hypodense\\.\\ \\ calcification\\ on\\ ct\\ favors\\ meningioma\\.\\ \\ cystic\\ degeneration\\ favors\\ schwannoma\\ whereas\\ fatty\\ degeneration\\ favors\\ meningioma\\.\\ \\ in\\ this\\ study\\ there\\ were\\ osseous\\ changes\\ consistent\\ with\\ meningioma\\.\\ \\ a\\ diagnosis\\ to\\ be\\ considered\\ is\\ a\\ meningioma\\ and\\ a\\ trigeminal\\ schwannoma\\ which\\ can\\ be\\ seen\\ in\\ neurofibromatosis\\ type\\ 2\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ meningioma\\:\\ 0\\.4331044370508454\ \(0\)\
\-\ favors\\:\\ 0\\.3116446449068571\ \(0\)\
\-\ trigeminal\\:\\ 0\\.2744098234769845\ \(0\)\
\-\ schwannoma\\:\\ 0\\.2122795977820311\ \(0\)\
\-\ paresthesias\\:\\ 0\\.18984188980882827\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.16376408772680684\ \(0\)\
\-\ degeneration\\:\\ 0\\.15357435793107077\ \(0\)\
\-\ broad\\:\\ 0\\.14915717351856306\ \(0\)\
\-\ dural\\:\\ 0\\.14654729609858919\ \(0\)\
\-\ component\\:\\ 0\\.1415197318546874\ \(0\)\
\-\ interclinoid\\:\\ 0\\.1320486318356047\ \(0\)\
\-\ transosseous\\:\\ 0\\.1320486318356047\ \(0\)\
\-\ into\\:\\ 0\\.13167959457307\ \(0\)\
\-\ and\\:\\ 0\\.11943566635598264\ \(0\)\
\-\ perioral\\:\\ 0\\.11878530742258644\ \(0\)\
\-\ extending\\:\\ 0\\.11196807729999267\ \(0\)\
\-\ ovale\\:\\ 0\\.1049542624988544\ \(0\)\
\-\ quadrigeminal\\:\\ 0\\.10388154830228569\ \(0\)\
\-\ bilobed\\:\\ 0\\.10288287527757284\ \(0\)\
\-\ schwannomas\\:\\ 0\\.10107113658830717\ \(0\)\
\-\ the\\:\\ 0\\.0988551594167517\ \(0\)\
\-\ meningiomas\\:\\ 0\\.09669561566679756\ \(0\)\
\-\ subjective\\:\\ 0\\.09548866541512793\ \(0\)\
\-\ isodense\\:\\ 0\\.09237492442272933\ \(0\)\
\-\ mandibular\\:\\ 0\\.09021044995113725\ \(0\)\
\-\ unenhanced\\:\\ 0\\.09021044995113725\ \(0\)\
\-\ extraaxial\\:\\ 0\\.089813849319264\ \(0\)\
\-\ whereas\\:\\ 0\\.08763851179460136\ \(0\)\
\-\ exams\\:\\ 0\\.08381491311340518\ \(0\)\
\-\ consultation\\:\\ 0\\.08330696564373485\ \(0\)\
\-\ tail\\:\\ 0\\.08143662356455457\ \(0\)\
\-\ with\\:\\ 0\\.08084194214175426\ \(0\)\
\-\ cistern\\:\\ 0\\.08017713235669699\ \(0\)\
\-\ hypodense\\:\\ 0\\.08017713235669699\ \(0\)\
\-\ fatty\\:\\ 0\\.07847222084999055\ \(0\)\
\-\ workup\\:\\ 0\\.07777449458084866\ \(0\)\
\-\ hyperdense\\:\\ 0\\.07601292931283009\ \(0\)\
\-\ 46\\:\\ 0\\.07586292778875667\ \(0\)\
\-\ plate\\:\\ 0\\.07571446476896668\ \(0\)\
\-\ solitary\\:\\ 0\\.07556750901398122\ \(0\)\
\-\ which\\:\\ 0\\.07509149841696613\ \(0\)\
\-\ undergoing\\:\\ 0\\.07499416604542354\ \(0\)\
\-\ hearing\\:\\ 0\\.07499416604542354\ \(0\)\
\-\ foramen\\:\\ 0\\.07339897365933905\ \(0\)\
\-\ tubular\\:\\ 0\\.07173607964958777\ \(0\)\
\-\ cavernous\\:\\ 0\\.07162430289695564\ \(0\)\
\-\ ligament\\:\\ 0\\.0709711838049864\ \(0\)\
\-\ distribution\\:\\ 0\\.07004364123071659\ \(0\)\
\-\ pending\\:\\ 0\\.06791248096839157\ \(0\)\
\-\ neurological\\:\\ 0\\.06782657556766385\ \(0\)\
\-\ be\\:\\ 0\\.06699131818959349\ \(0\)\
\-\ compared\\:\\ 0\\.06675386137109512\ \(0\)\
\-\ osseous\\:\\ 0\\.06590441665299139\ \(0\)\
\-\ initially\\:\\ 0\\.06475156744346806\ \(0\)\
\-\ slightly\\:\\ 0\\.06440935250860796\ \(0\)\
\-\ considered\\:\\ 0\\.06434186978714285\ \(0\)\
\-\ currently\\:\\ 0\\.0634287281365292\ \(0\)\
\-\ mass\\:\\ 0\\.06307965735114184\ \(0\)\
\-\ worsening\\:\\ 0\\.0630543533671675\ \(0\)\
\-\ base\\:\\ 0\\.0628100434742027\ \(0\)\
\-\ are\\:\\ 0\\.06266370141561438\ \(0\)\
\-\ in\\:\\ 0\\.0616227810627325\ \(0\)\
\-\ sinus\\:\\ 0\\.05966507686896762\ \(0\)\
\-\ calcification\\:\\ 0\\.058951877570520034\ \(0\)\
\-\ nerve\\:\\ 0\\.0589055574748746\ \(0\)\
\-\ extension\\:\\ 0\\.058450330727766814\ \(0\)\
\-\ involving\\:\\ 0\\.057836146945451854\ \(0\)\
\-\ type\\:\\ 0\\.055391627891171975\ \(0\)\
\-\ surrounding\\:\\ 0\\.05506875165997281\ \(0\)\
\-\ study\\:\\ 0\\.05506875165997281\ \(0\)\
\-\ right\\:\\ 0\\.054751251263408025\ \(0\)\
\-\ loss\\:\\ 0\\.05030513731667154\ \(0\)\
\-\ changes\\:\\ 0\\.04990232822768526\ \(0\)\
\-\ cystic\\:\\ 0\\.04972956381917235\ \(0\)\
\-\ presented\\:\\ 0\\.04815059424686677\ \(0\)\
\-\ who\\:\\ 0\\.04670712311667003\ \(0\)\
\-\ is\\:\\ 0\\.04522513095394723\ \(0\)\
\-\ consistent\\:\\ 0\\.04477176525365825\ \(0\)\
\-\ can\\:\\ 0\\.043330522558826114\ \(0\)\
\-\ diagnosis\\:\\ 0\\.042804100271667395\ \(0\)\
\-\ were\\:\\ 0\\.04256284439465114\ \(0\)\
\-\ to\\:\\ 0\\.041285059016798055\ \(0\)\
\-\ had\\:\\ 0\\.04113979192633073\ \(0\)\
\-\ seen\\:\\ 0\\.038873648454277876\ \(0\)\
\-\ there\\:\\ 0\\.032854651857293866\ \(0\)\
\-\ ct\\:\\ 0\\.03143546616482714\ \(0\)\
\-\ pain\\:\\ 0\\.029546859076867337\ \(0\)\
\-\ or\\:\\ 0\\.028724899486262907\ \(0\)\
\-\ this\\:\\ 0\\.02837280245324874\ \(0\)\
\-\ patient\\:\\ 0\\.026856125296622964\ \(0\)\
\-\ year\\:\\ 0\\.02544668465099332\ \(0\)\
\-\ for\\:\\ 0\\.025026565715556115\ \(0\)\
\-\ on\\:\\ 0\\.024937788880779736\ \(0\)\
\-\ old\\:\\ 0\\.024437625853444528\ \(0\)\
\-\ of\\:\\ 0\\.016158733588881907\ \(0\)\
